Clinical Trials Logo

Locally Advanced Chordoma clinical trials

View clinical trials related to Locally Advanced Chordoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT03623854 Completed - Chordoma Clinical Trials

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Start date: April 3, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well nivolumab and relatlimab work in treating participants with chordoma that has spread to other places in the body. Monoclonal antibodies, such as nivolumab and relatlimab, may interfere with the ability of tumor cells to grow and spread.